D.E. Shaw & Co’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-105,130
Closed -$1.13M 3041
2024
Q4
$1.13M Buy
+105,130
New +$1.13M ﹤0.01% 2079
2024
Q3
Sell
-58,355
Closed -$246K 3155
2024
Q2
$246K Sell
58,355
-11,263
-16% -$47.5K ﹤0.01% 2764
2024
Q1
$354K Buy
69,618
+16,164
+30% +$82.3K ﹤0.01% 2539
2023
Q4
$498K Buy
53,454
+20,913
+64% +$195K ﹤0.01% 2369
2023
Q3
$213K Sell
32,541
-12,563
-28% -$82.3K ﹤0.01% 2565
2023
Q2
$367K Buy
+45,104
New +$367K ﹤0.01% 2436
2023
Q1
Sell
-46,190
Closed -$428K 3304
2022
Q4
$428K Sell
46,190
-257,959
-85% -$2.39M ﹤0.01% 2778
2022
Q3
$3.14M Sell
304,149
-73,205
-19% -$756K ﹤0.01% 1832
2022
Q2
$3.78M Buy
377,354
+67,962
+22% +$680K ﹤0.01% 1817
2022
Q1
$3.81M Buy
309,392
+292,864
+1,772% +$3.61M ﹤0.01% 1925
2021
Q4
$287K Sell
16,528
-28,351
-63% -$492K ﹤0.01% 3330
2021
Q3
$806K Sell
44,879
-54,814
-55% -$984K ﹤0.01% 2602
2021
Q2
$2.28M Buy
99,693
+48,244
+94% +$1.1M ﹤0.01% 1988
2021
Q1
$769K Buy
+51,449
New +$769K ﹤0.01% 2317
2020
Q3
Sell
-31,195
Closed -$153K 2573
2020
Q2
$153K Sell
31,195
-29,563
-49% -$145K ﹤0.01% 2498
2020
Q1
$191K Sell
60,758
-10,792
-15% -$33.9K ﹤0.01% 2466
2019
Q4
$185K Buy
+71,550
New +$185K ﹤0.01% 2518
2019
Q3
Sell
-35,587
Closed -$120K 2552
2019
Q2
$120K Buy
+35,587
New +$120K ﹤0.01% 2473
2018
Q1
Sell
-16,140
Closed -$52K 2494
2017
Q4
$52K Buy
+16,140
New +$52K ﹤0.01% 2480
2016
Q4
Sell
-119,534
Closed -$434K 2479
2016
Q3
$434K Buy
119,534
+105,080
+727% +$382K ﹤0.01% 2058
2016
Q2
$88K Buy
+14,454
New +$88K ﹤0.01% 2456